EV2-25090-82790
5 vaccinations
5 coded responses
49 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 214 / MD
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Moderna
-
2021-03-22
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Slight soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
-
2021-04-19
Dose 2 — Moderna
-
2021-04-19
Survey response — day 0, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: very very minor soreness at injection locationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Injection site reaction — Feeling: Fair · HeadacheFree text: very mild sensation at injection site, very mild headache this afternoonMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
-
2021-11-24
Dose 3 — Moderna
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-08
- 2022-02-23
-
2022-05-12
Dose 4 — Pfizer-BioNTech
- 2022-05-19
- 2022-05-26
-
2022-06-15
Survey response — day 28, dose 4MedDRA: Laboratory test abnormal — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: was in Europe/UK for 2 weeks, leaving two weeks after my fourth shot/second booster. OK while in Europe/UK, took a rapid test Monday afternoon to ensure I was good to fly back to the USA on Tuesday, negative. Tested positive on Wednesday morningMedDRA releases: 2024-11 · check-in free text available
-
2022-06-16
Survey response — day 35, dose 4MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have COVID-19 symptoms and tested positive Wednesday morningMedDRA releases: 2024-11 · check-in free text available
- 2022-06-23
- 2022-08-15
-
2022-10-17
Dose 5 — ModernaCo-administered: Flu:Shingles
-
2022-10-18
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-11-21
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna | |
| 3 | 2021-11-24 | Moderna | No |
| 4 | 2022-05-12 | Pfizer-BioNTech | No |
| 5 | 2022-10-17 | Moderna | Flu:Shingles |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Slight soreness at injection site
Release 7 — day 0, dose 2
Systemic reaction (other): very very minor soreness at injection location
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): very mild sensation at injection site, very mild headache this afternoon
Release 12 — day 28, dose 4
Symptoms: was in Europe/UK for 2 weeks, leaving two weeks after my fourth shot/second booster. OK while in Europe/UK, took a rapid test Monday afternoon to ensure I was good to fly back to the USA on Tuesday, negative. Tested positive on Wednesday morning
Release 12 — day 35, dose 4
Symptoms: I have COVID-19 symptoms and tested positive Wednesday morning
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release